Pfizer to sell Schneider angio unit

Article

Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider

Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider Worldwide business, which develops interventional radiology and cardiology products such as angioplasty balloon catheters. Other units in the business include Howmedica, which develops orthopedic devices, and American Medical Systems, a developer of urological implants. Pfizer was active in the medical imaging market in the 1980s, marketing such technologies as CT and mammography, but eventually exited the business.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.